Skip to main content
. Author manuscript; available in PMC: 2013 Oct 28.
Published in final edited form as: J Urol. 2011 Jun 16;186(2):10.1016/j.juro.2011.03.105. doi: 10.1016/j.juro.2011.03.105

Table 1.

Treatment, Failure, and Preoperative Urodynamic Characteristics of Women Enrolled in the TOMUS trial

Total
No.
Treatment 597
  TMUS 299 (50.1)
  RMUS 298 (49.9)
Objective failure 559
  Yes 124 (22.2)
  No 435 (77.8)
Subjective failure 564
  Yes 245 (43.4)
  No 319 (56.6)
Any failure (objective and/or subjective) 565
  Yes 260 (46.0)
No 305 (54.0)
Urodynamic stress incontinence (USI) 589
  Yes 505 (85.7)
  No 84 (14.3)
Detrusor overactivity (DO) 589
  Yes 70 (11.9)
  No 519 (88. 1)
At what point did the patient leak 589
  Leakage w/ Valsalva 418 (71.0)
  Leakage w/ cough at MCC only 87 (14.8)
  No leakage 84 (14.3)
VLPP (cm H2O) (atmospheric reference) 119 (42) 372
MUCP (cm H2O) 68 (33) 539
FUL (mm) 32 (8) 539
First desire (cc) 117 (80) 586
Strong desire (cc) 227 (118) 585
MCC (cc) 351(123) 589
NIF Qmax (cc/s) 25 (12) 550
PFS Qmax (cc/s) 22 (11) 556
pves @Qmax (cm H2O) 56 (26) 401
 pabd@Qmax (cm H2O) 37 (27) 401
Delta pdet @ Qmax (cm H2O) 19 (13) 401
PVR at NIF (cc) 24 (42) 502
Vesical compliance (cc/cm H2O) 68 (127) 513
Detrusor compliance (cc/cm H2O) 53 (144) 496
*

Frequency (%) for categorical variables and Mean (SD) for continuous variables